Worth Asset Management »

SPDR S&P Biotech shares owned by Worth Asset Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Worth Asset Management from 13F filings

Historical chart of Worth Asset Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Worth Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Worth Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2M 13k 94.92
2022-12-31 $20k 240 83.00

More positions owned by Worth Asset Management

Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Ishares Iboxx $ High Yield Corporate Bond Etf Etf (HYG)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard Growth Etf Etf (VUG)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Neos Enhanced Income Ca Alt Etf Etf (CSHI)
Nvidia Corporation Stock (NVDA)
Vanguard Total Bond Market Etf Etf (BND)
Apple Stock (AAPL)
Broadcom Stock (AVGO)
Meta Platforms Inc Cl A Stock (META)
General Mtrs Stock (GM)
American Express Stock (AXP)
Caterpillar Stock (CAT)
Lam Research Corp Stock (LRCX)

View all positions for Worth Asset Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors
Gts Securities
Brown Advisory Holdings Incorporated

View all funds holding SPDR S&P Biotech